Status:
COMPLETED
Efficacy of Antituberculous Therapy in Management of Sarcoidosis
Lead Sponsor:
Post Graduate Institute of Medical Education and Research, Chandigarh
Conditions:
Sarcoidosis
Tuberculosis
Eligibility:
All Genders
15-75 years
Phase:
NA
Brief Summary
From the time sarcoidosis has been described, there has always been a belief that the disease is in some way related to tuberculosis. If indeed tuberculosis is a causal factor in sarcoidosis, then the...
Detailed Description
Sarcoidosis has evolved from the position of a disease of relative obscurity in the tropics, towards an increasing recognition and reporting from India and around. From the time sarcoidosis has been d...
Eligibility Criteria
Inclusion
- newly diagnosed sarcoidosis defined by presence of all of the following criteria:
- Presence with clinical features of pulmonary (dyspnea, dry cough, chest pain, fever, fatigue or crackles) or extra pulmonary organ (lymph nodes, liver, spleen, skin, eyes, heart, etc.) involvement and consistent radiological involvement and
- Compact non-caseating granulomas on trans-bronchial biopsy which are tissue AFB smear-negative
Exclusion
- Patients who have received glucocorticoid treatment before initial evaluation by us, or with presence of concomitant other cardio pulmonary disease will be excluded.
Key Trial Info
Start Date :
January 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 1 2013
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT01245036
Start Date
January 1 2009
End Date
March 1 2013
Last Update
May 15 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Deaprtment of Pulmonary Medicine, PGIMER
Chandigarh, Chandigarh, India, 160012